PubMed · 8711320
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
H Greifzu. 1996. Chemo quick guide. Hormonal agents.. https://pubmed.ncbi.nlm.nih.gov/8711320/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
The majority of breast cancers express the estrogen receptor (ERα) and agents targeting this pathway represent the main treatment modality. Endocrine therapy has proven successful in the treatment of hormone-responsive breast cancer since its early adoption in the 1940s as an ablative therapy. Unfortunately, therapeutic resistance arises, leading to disease recurrence and relapse. Recent studies increased our understanding in how changes to the chromatin landscape and deregulation of epigenetic factors orchestrate the resistant phenotype. Here, we will discuss how the epigenome is an integral determinant in hormone therapy response and why epigenetic factors are promising targets for overcoming clinical resistance.
Explore the source record for details and available documents.
Explore the source record for details and available documents.